Bispecific t cell activating antigen binding molecules
US-2026022172-A1 · Jan 22, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ast Oliver patents
Ast Oliver is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ast Oliver |
| Total patents | 35 |
| First publication | Feb 23, 2016 |
| Latest publication | Jan 22, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Bispecific t cell activating antigen binding molecules
US-2025043028-A1 · Feb 6, 2025 · US
Bispecific t cell activating antigen binding molecules
US-2024425616-A1 · Dec 26, 2024 · US
Bispecific t cell activating antigen binding molecules
US-2024141044-A1 · May 2, 2024 · US
Bispecific antibodies against CD3EPSILON and ROR1
US-11952421-B2 · Apr 9, 2024 · US
Bispecific t cell activating antigen binding molecules
US-2023340160-A1 · Oct 26, 2023 · US
Bispecific t cell activating antigen binding molecules
US-2023287118-A1 · Sep 14, 2023 · US
Bispecific t cell activating antigen binding molecules
US-2022403027-A1 · Dec 22, 2022 · US
Novel immunoconjugates
US-2022242971-A1 · Aug 4, 2022 · US
Immunoconjugates
US-11130822-B2 · Sep 28, 2021 · US
Recent patents
Latest publications not already listed above.
Bispecific T cell activating antigen binding molecules
US-11117965-B2 · Sep 14, 2021 · US
Mutant interleukin-2 polypeptides
US-11111312-B2 · Sep 7, 2021 · US
Bispecific t cell activating antigen binding molecules
US-2020231673-A1 · Jul 23, 2020 · US
Bispecific T cell activating antigen binding molecules
US-10611840-B2 · Apr 7, 2020 · US
Bispecific T cell activating antigen binding molecules
US-10611841-B2 · Apr 7, 2020 · US
Mutant interleukin-2 polypeptides
US-2019322765-A1 · Oct 24, 2019 · US
Novel immunoconjugates
US-2019322763-A1 · Oct 24, 2019 · US
Novel immunoconjugates
US-2019315883-A1 · Oct 17, 2019 · US
Mutant interleukin-2 polypeptides
US-10323098-B2 · Jun 18, 2019 · US
Immunoconjugates
US-10316104-B2 · Jun 11, 2019 · US
Mutant interleukin-2 polypeptides
US-2019077881-A1 · Mar 14, 2019 · US
Immunoconjugates
US-10202464-B2 · Feb 12, 2019 · US
Mutant interleukin-2 polypeptides
US-10184009-B2 · Jan 22, 2019 · US
Anti-cd3xrob04 bispecific t cell activating antigen binding molecules
US-2018282410-A1 · Oct 4, 2018 · US
Bispecific t cell activating antigen binding molecules
US-2018273643-A1 · Sep 27, 2018 · US
Bispecific t cell activating antigen binding molecules
US-2018222980-A1 · Aug 9, 2018 · US
Bispecific t cell activating antigen binding molecules
US-2018222981-A1 · Aug 9, 2018 · US
Mutant interleukin-2 polypeptides
US-2018142037-A1 · May 24, 2018 · US
Bispecific T cell activating antigen binding molecules
US-9914776-B2 · Mar 13, 2018 · US
Novel immunoconjugates
US-2017088631-A1 · Mar 30, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Roche Glycart Ag | 20 |
| Hoffmann La Roche | 13 |
| Ast Oliver | 2 |
| Bruenker Peter | 2 |
| Hofer Thomas U | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 35 |
| A61K2039/505 | 30 |
| C07K2317/92 | 26 |
| C07K2317/55 | 26 |
| C07K2317/732 | 22 |